The anticipated size of the focused ultrasound system market in 2022 was US$ 7,014.5 million and is estimated to be US$ 7,353.85 million in 2023. The emergence of markets would be the most affected, as the growth of the population in developing countries is anticipated to be rapid, which resulted in increased healthcare spending. Future Market Insights has mentioned in its reports that the focused ultrasound system market will expand at a CAGR of 6.1% between 2023 and 2033, totaling around US$ 13,281.55 million by 2033.
Over the years, focused ultrasound systems have gained immense traction across the healthcare industry on account of their non-invasive nature. This medical equipment is used to perform focused ultrasound i.e., an image-guided, non-invasive procedure that uses sound waves to treat numerous health conditions such as tremors and Alzheimer's disease.
Focused ultrasound systems allow medical professionals to use ultrasound energy to target a specific area without affecting the surrounding tissues. The growing adoption of focused ultrasound for non-invasive and site-specific treatment of different diseases is proving a major impetus to market growth.
Similarly, easy acceptance of focused ultrasound systems by healthcare workers and patients is expected to drive market growth.
By technology, the MR-guided focused ultrasound system is anticipated to lead market growth due to its high efficiency. The application of focused ultrasound systems is expected to grow further in the oncology sector while hospitals are set to drive the market growth of focused ultrasound systems from the end-user segment.
Attributes | Details |
---|---|
Projected Forecast Value (2022) | US$ 7,014.5 million |
Projected Forecast Value (2023) | US$ 7,353.85 million |
Projected Forecast Value (2033) | US$ 13,281.55 million |
Growth rate | 6.1% CAGR |
Forecast period | 2023 to 2033 |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Global focused ultrasound system market grew at a CAGR of 3.9% between 2017 and 2022. Growth forecasts remain optimistic, with the market predicted to exhibit a CAGR of 6.1% between 2023 and 2033.
Government initiatives thus raise awareness about the importance of early detection which has increased the demand for ultrasonic imaging instruments. Surge in demand for ultrasound imaging devices is mainly used for nominal invasive diagnostic and therapeutic applications, as well as for the introduction of more technologically advanced ultrasound equipment, where the demand for ultrasound imaging devices has increased over the previous year.
Usage of ultrasound technologies for diagnosing patients earlier contributes to lower overall healthcare costs. Usage of ultrasound devices is also anticipated to rise as the number of patients with chronic conditions increases, by fuelling the market's expansion.
Rise in the Prevalence of Various Chronic Diseases
Rising prevalence of various chronic diseases such as cancer and Alzheimer's disease and the growing preference for non-invasive treatment procedures are some of the major factors pushing the demand for focused ultrasound systems.
Focused ultrasound systems have become highly sought-after medical devices used for the treatment of a wide range of diseases on account of their various benefits. These medical systems offer a non-invasive and site-specific treatment, reduce hospital lengths of stay, and eliminate the need for analgesics. Besides this, treatment with focused ultrasound systems only requires around 2 to 4 hours. All these factors together drive the market demand for focused ultrasound systems.
Rise in Adoption of Focused Ultrasound
Increasing adoption of focused ultrasound for acquired real-time monitoring is expected to boost the sales of focused ultrasound systems during the forecast period. Healthcare workers are increasingly using focused ultrasound systems along with MRI scanners to see real-time visuals of tissues that require treatment. This improves the preciseness and the outcome of the treatment.
Increase in Investments in Research and Development
Rising investments in research and development and a surge in the growing number of clinical trials by manufacturers of focused ultrasound systems are expected to propel market growth.
Penetration of Focused Ultrasound Systems is Low in Middle and Low-Income Countries
Focused ultrasound system has certain aspects that impede the growth of the market. The product penetration of focused ultrasound systems is notably low in middle and low-income countries. This is expected to hamper the growth of the focused ultrasound systems market.
High Cost of Ultrasound Machines
Factors such as the discomfort experienced by patients during the treatment, certain risks of bleeding, and the high cost of ultrasound machines might also impede the growth of the focused ultrasound systems market during the assessment period.
North America is expected to hold a significant share in the global focused ultrasound systems market with a market share of 20%. High product penetration of focused ultrasound systems in the region is a prime reason for this lead. The advanced healthcare sector and a higher number of medical procedures taking place in the region also aid market growth.
United States has a dominant share in this market with a value share of 16.7% where easy compliance and preference of patients for non-invasive procedures will also propel market growth for focused ultrasound systems in the region.
Growing healthcare infrastructure and increasing investments in the healthcare field are set to expand the Asia Pacific-focused ultrasound market. Asia Pacific is predicted to be the fastest-growing focused ultrasound systems market. Rapidly expanding and improving the healthcare sector in emerging economies like China expanding at a CAGR of 7.6% and India expanding at a CAGR of 5.6% is thus anticipated to drive a focused ultrasound systems market in the Asia Pacific.
Rising prevalence of various chronic diseases such as cancer, brain tumor, and Parkinson's disease, and growing health awareness among people are igniting the demand for early diagnosis and treatment of these diseases. This in turn is creating space for the growth of the focused ultrasound systems market in the region.
Rise in awareness and diagnosis of early disease and the technological advancements in the ultrasound imaging market for ultrasound imaging devices in Europe is seen to be expanding. Increase in the geriatric population and the increase in demand for ultrasound imaging technologies are thus used for least-invasive diagnostic and therapeutic purposes that will help in accelerating the market expansion.
Europe, therefore has a market share of 33.7% with the United Kingdom consisting of a major portion, expanding at a CAGR of 5.1%.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Ultrasound-guided machines have a value share of 56% and are now considered to be employed in emergency departments mainly for giving anesthesia, by expanding their range of potential uses. Manufacturers are on the verge of introducing newer technologies, for example, 3D and 4D imaging, so as to make their devices smaller and more portable because of technological improvements, which will further boost the growth of the portable ultrasound segment.
Trials are done in a number of areas in the case of urology with a market share of 42.3% which is considered to be the most promising at this present moment and is also used for the treatment of renal and prostate cancers. Treatment of renal cancer is currently limited due to the position of the kidneys and the presence of ribs and perinephric fat, but nowadays treatment for prostate cancer is becoming more established.
The globally focused ultrasound system market is fairly competitive. Some of the leading players present in the market include Alpinion Medical Systems Co., Ltd., INSIGHTEC Ltd., Sonacare Medical, General Electric Company, Siemens Ltd., Haifu Medical Technology Co., Ltd., FUS Instruments, MEDSONIC LTD, Mirabilis Medical, Inc., EDAP among others.
Leading companies in the market are investing in research and development activities so as to expand their existing product portfolios. For instance, Israel-based INSIGHTEC Ltd., is focusing its energies on developing a focused ultrasound system for the treatment of Parkinson’s disease. This ultrasound system is in stage three of clinical trials for FDA approval.
Report Attributes | Details |
---|---|
Growth Rate | CAGR of 6.1% from 2023 to 2033 |
Base Year for Estimation | 2022 |
Historical Data | 2017 to 2022 |
Forecast Period | 2023 to 2033 |
Quantitative Units | Revenue in US$ million, and CAGR from 2023 to 2033 |
Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
Segments Covered |
|
Regions Covered |
|
Countries Covered |
|
Key Companies Profiled |
|
Customization | Available Upon Request |
The projected revenue of the market by 2033 is US$ 13,281.55 million.
The market CAGR for 2033 is projected to be 6.1%.
The market is valued at US$ 7.353.85 million in 2023.
North America holds a substantial market share.
Increase in clinical trials driving the market in North America.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Technology
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Technology, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Technology, 2023 to 2033
5.3.1. Ultrasound-Guided
5.3.2. MR-Guided
5.4. Y-o-Y Growth Trend Analysis By Technology, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Technology, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033
6.3.1. Oncology
6.3.2. Neurosurgery
6.3.3. Urology
6.3.4. Cosmetics
6.3.5. Other
6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
7.3.1. Hospitals
7.3.2. Laboratories
7.3.3. Specialty Clinics
7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA.
9.2.1.2. Canada
9.2.2. By Technology
9.2.3. By Application
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Technology
9.3.3. By Application
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Technology
10.2.3. By Application
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Technology
10.3.3. By Application
10.3.4. By End User
10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Technology
11.2.3. By Application
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Technology
11.3.3. By Application
11.3.4. By End User
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Technology
12.2.3. By Application
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Technology
12.3.3. By Application
12.3.4. By End User
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Technology
13.2.3. By Application
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Technology
13.3.3. By Application
13.3.4. By End User
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Technology
14.2.3. By Application
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Technology
14.3.3. By Application
14.3.4. By End User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Technology
15.2.3. By Application
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Technology
15.3.3. By Application
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA.
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Technology
16.1.2.2. By Application
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Technology
16.2.2.2. By Application
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Technology
16.3.2.2. By Application
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Technology
16.4.2.2. By Application
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Technology
16.5.2.2. By Application
16.5.2.3. By End User
16.6. United Kingdom.
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Technology
16.6.2.2. By Application
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Technology
16.7.2.2. By Application
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Technology
16.8.2.2. By Application
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Technology
16.9.2.2. By Application
16.9.2.3. By End User
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Technology
16.10.2.2. By Application
16.10.2.3. By End User
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Technology
16.11.2.2. By Application
16.11.2.3. By End User
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Technology
16.12.2.2. By Application
16.12.2.3. By End User
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Technology
16.13.2.2. By Application
16.13.2.3. By End User
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Technology
16.14.2.2. By Application
16.14.2.3. By End User
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Technology
16.15.2.2. By Application
16.15.2.3. By End User
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Technology
16.16.2.2. By Application
16.16.2.3. By End User
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Technology
16.17.2.2. By Application
16.17.2.3. By End User
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Technology
16.18.2.2. By Application
16.18.2.3. By End User
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Technology
16.19.2.2. By Application
16.19.2.3. By End User
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Technology
16.20.2.2. By Application
16.20.2.3. By End User
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Technology
16.21.2.2. By Application
16.21.2.3. By End User
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Technology
16.22.2.2. By Application
16.22.2.3. By End User
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Technology
16.23.2.2. By Application
16.23.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Technology
17.3.3. By Application
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Alpinion Medical Systems Co., Ltd
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. INSIGHTEC Ltd.
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. Sonacare Medical
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. General Electric Company
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. Siemens Ltd.
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. Haifu Medical Technology Co. Ltd.
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. FUS Instruments
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. MEDSONIC LTD
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. Mirabilis Medical, Inc.
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
18.1.10. EDAP
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.10.5.2. Product Strategy
18.1.10.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports